SCHEMBL15948340

SCHEMBL15948340

NC(=O)CNC(=O)CCCOc1ccc(C(=O)c2ccc(N=C=S)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 1/20 0.40
▸ HPGD P15428 5/20 0.39
▸ HTT P42858 1/20 0.39
▸ TAAR1 Q96RJ0 1/20 0.38
▸ PRSS1 P07477 1/20 0.37
▸ ACR P10323 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ SIRT3 Q9NTG7 1/20 0.37
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ MMP1 P03956 1/20 0.37
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ GAA P10253 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ FURIN P09958 1/20 0.36
▸ KDM1A O60341 1/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15946451 0.94 TSHR (0.38) PPARAPRSS1ACRLMNAMMP1
SCHEMBL14821114 0.91 PPARA (0.40) PPARAHPGDHTTTAAR1PRSS1
SCHEMBL14821476 0.90 PPARA (0.46) PPARAHPGDHTTTAAR1LMNA
SCHEMBL14821011 0.88 HPGD (0.44) PPARAHPGDHTTLMNASIRT3
SCHEMBL14821004 0.87 LMNA (0.46) HPGDHTTLMNAMEN1KMT2A
SCHEMBL14821002 0.85 TSHR (0.38) PPARAPRSS1ACRLMNAMMP1
SCHEMBL15948336 0.85 POLB (0.48) HPGDHTTLMNAMMP1SMN1; SMN2
SCHEMBL14821467 0.84 PPARA (0.44) PPARALMNASMN1; SMN2GAAALDH1A1
SCHEMBL14821003 0.82 TSHR (0.41) PPARAHPGDLMNAMEN1KMT2A
SCHEMBL15948351 0.81 TAAR1 (0.40) PPARAHPGDHTTTAAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2758367-B1 NOVEL ISOCYANATE AND ISOTHIOCYANATE COMPOUNDS FOR CANCER TREATMENT DoubleHill GmbH (DE) 2015-11-18 — — EP disclosed
US-8987316-B2 Isocyanate and isothiocyanate compounds for cancer treatment DoubleHill GmbH (DE) 2015-03-24 — — US disclosed
US-20140228419-A1 Novel Isocyanate And Isothiocyanate Compounds For Cancer Treatment DoubleHill GmbH (DE) 2014-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140228419-A1 Novel Isocyanate And Isothiocyanate Compounds For Cancer Treatment IDH3A, IDH3B, IDH2 PPARA 3425/4885HPGD 3189/4885HTT 58/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback